Structure-based, Rational Design of RhoGEF, GGTase I and RhoKinase Inhibitors
Structure-based, Rational Design of RhoGEF, GGTase I and RhoKinase Inhibitors
批准号:
7882864
负责人:
Nicolas Lawrence
金额:
$30.93万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30
关键词:
Biological AvailabilityBiological ProcessCardiovascular systemDiabetes MellitusDisadvantagedDiseaseFaceHIVHydrogen BondingMalignant NeoplasmsMediatingNeurodegenerative DisordersPeptidesPlayPositioning AttributeProtein-Serine-Threonine KinasesProteinsReportingRho-associated kinaseRoleSecondary Protein StructureSolubilityStructureSurfaceTherapeuticWaterbasedesignimprovedinhibitor/antagonistinnovationmimeticsmimicrynovelprotein geranylgeranyltransferaseprotein protein interactionrhoscaffoldsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Protein-protein Interactions (PPIs) play critical roles in biological processes that can propagate or terminate llfe.These PPIs have been Implicated In numerous disease states, including HIV, diabetes, and cardiovascular and neurodegenerative diseases, making them Important targets for dIsruptlon.Often recognition between proteins is mediated by protein secondary structures, such as a-helices, via one helical face, where interacting residues occupy predominantly the /, / + 3 or / + 4, and / + 7 positions. Accordingly, these surfaces are critical targets for small molecule mimicry. Our previous focus has yielded a-helix mimetics with Inherent disadvantages, either poor solubility (terphenyl and terpyridine scaffolds) or hydrogen-bonding networks to maintain their correct orientation (terephthalamide and thspyrldylamlde scaffolds). As a mechanism to overcome the disadvantages of our previous designs, we have reported an Innovative scaffold that replaces
the terminal six-membered aromatic end units with water-soluble five-membered heterocyclic groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金